siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells
siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells
About this item
Full title
Author / Creator
Dong, Xuejun , Liu, Anding , Zer, Cindy , Feng, Jianguo , Zhen, Zhuan , Yang, Mingfeng and Zhong, Li
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Doxorubicin is an effective breast cancer drug but is hampered by a severe, dose-dependent toxicity. Concomitant administration of doxorubicin and another cancer drug may be able to sensitize tumor cells to the cytotoxicity of doxorubicin and lowers the therapeutic dosage. In this study, we examined the combined effect of low-dose doxorubicin and s...
Alternative Titles
Full title
siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b6ab8bd871ee47daae87c9079fe0ab39
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b6ab8bd871ee47daae87c9079fe0ab39
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/1471-2407-9-133
